BioVie Inc. Amortization of Intangible Assets
BioVie Inc. (BIVI) reported Amortization of Intangible Assets of $178.34 thousand for the 12-month period ending 2026-06-30, per its 10-K filed 2026-08-13.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AmortizationOfIntangibleAssets · last filed 2026-08-13
- BioVie Inc. amortization of intangible assets for the quarter ending 2026-06-30 was $6.31K, a 89.00% decline year-over-year.
- BioVie Inc. amortization of intangible assets for the quarter ending 2026-03-31 was $57.34K, a 0.00% change year-over-year.
- BioVie Inc. amortization of intangible assets for the quarter ending 2025-12-31 was $57.34K, a 0.00% change year-over-year.
- BioVie Inc. amortization of intangible assets for the quarter ending 2025-09-30 was $57.34K, a 0.00% change year-over-year.
- BioVie Inc. amortization of intangible assets for fiscal 2026 was $178.34K, a 22.25% decline from fiscal 2025.
- BioVie Inc. amortization of intangible assets for fiscal 2025 was $229.38K.
- BioVie Inc. amortization of intangible assets for fiscal 2023 was $229.38K, a 0.00% change from fiscal 2022.
- BioVie Inc. amortization of intangible assets for fiscal 2022 was $229.38K, a 0.00% change from fiscal 2021.
| Period end | Amortization of Intangible Assets 3 month | Amortization of Intangible Assets 6 month | Amortization of Intangible Assets 9 month | Amortization of Intangible Assets 12 month |
|---|---|---|---|---|
| 2026-06-30 | $6.31K derived: 10-K 12 month − S-1/A 9 month · filed 2026-08-13 | $63.65K derived: sum of 2 quarters · filed 2026-08-13 | $121.00K derived: sum of 3 quarters · filed 2026-08-13 | $178.34K 10-K · filed 2026-08-13 |
| 2026-03-31 | $57.34K S-1/A · filed 2026-08-06 | $114.69K derived: sum of 2 quarters · filed 2026-08-06 | $172.03K S-1/A · filed 2026-08-06 | $229.38K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | $57.34K 10-Q · filed 2026-02-06 | $114.69K 10-Q · filed 2026-02-06 | $172.03K derived: sum of 3 quarters · filed 2026-08-13 | $229.38K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-09-30 | $57.34K 10-Q · filed 2025-11-10 | $114.69K derived: sum of 2 quarters · filed 2026-08-13 | $172.03K derived: sum of 3 quarters · filed 2026-08-13 | $229.38K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | $57.34K derived: 10-K 12 month − S-1/A 9 month · filed 2026-08-13 | $114.69K derived: sum of 2 quarters · filed 2026-08-13 | $172.03K derived: sum of 3 quarters · filed 2026-08-13 | $229.38K 10-K · filed 2026-08-13 |
| 2025-03-31 | $57.34K S-1/A · filed 2026-08-06 | $114.69K derived: sum of 2 quarters · filed 2026-08-06 | $172.03K S-1/A · filed 2026-08-06 | $229.38K derived: sum of 4 quarters · filed 2026-08-06 |
| 2024-12-31 | $57.34K 10-Q · filed 2026-02-06 | $114.69K 10-Q · filed 2026-02-06 | $172.03K derived: sum of 3 quarters · filed 2026-08-06 | $229.38K derived: sum of 4 quarters · filed 2026-08-06 |
| 2024-09-30 | $57.34K 10-Q · filed 2025-11-10 | $114.69K derived: sum of 2 quarters · filed 2026-08-06 | $172.03K derived: sum of 3 quarters · filed 2026-08-06 | $229.38K derived: sum of 4 quarters · filed 2026-08-06 |
| 2024-06-30 | $57.34K derived: S-1/A 12 month − 10-Q 9 month · filed 2026-08-06 | $114.69K derived: sum of 2 quarters · filed 2026-08-06 | $172.03K derived: sum of 3 quarters · filed 2026-08-06 | $229.38K S-1/A · filed 2026-08-06 |
| 2024-03-31 | $57.34K 10-Q · filed 2025-05-12 | $114.69K derived: sum of 2 quarters · filed 2025-05-12 | $172.03K 10-Q · filed 2025-05-12 | $229.38K derived: sum of 4 quarters · filed 2025-05-12 |
| 2023-12-31 | $57.34K 10-Q · filed 2025-02-11 | $114.69K 10-Q · filed 2025-02-11 | $172.03K derived: sum of 3 quarters · filed 2025-02-11 | $229.38K derived: sum of 4 quarters · filed 2025-02-11 |
| 2023-09-30 | $57.34K 10-Q · filed 2024-11-13 | $114.69K derived: sum of 2 quarters · filed 2024-11-13 | $172.03K derived: sum of 3 quarters · filed 2024-11-13 | $229.38K derived: sum of 4 quarters · filed 2024-11-13 |
| 2023-06-30 | $57.34K derived: 10-K 12 month − 10-Q 9 month · filed 2024-09-30 | $114.69K derived: sum of 2 quarters · filed 2024-09-30 | $172.03K derived: sum of 3 quarters · filed 2024-09-30 | $229.38K 10-K · filed 2024-09-30 |
| 2023-03-31 | $57.34K 10-Q · filed 2024-05-14 | $114.69K derived: sum of 2 quarters · filed 2024-05-14 | $172.03K 10-Q · filed 2024-05-14 | $229.38K derived: sum of 4 quarters · filed 2024-05-14 |
| 2022-12-31 | $57.34K 10-Q · filed 2024-02-13 | $114.69K 10-Q · filed 2024-02-13 | $172.03K derived: sum of 3 quarters · filed 2024-02-13 | $229.38K derived: sum of 4 quarters · filed 2024-02-13 |
| 2022-09-30 | $57.34K 10-Q · filed 2023-11-08 | $114.69K derived: sum of 2 quarters · filed 2023-11-08 | $172.03K 10-Q · filed 2022-05-11 | $229.38K derived: sum of 4 quarters · filed 2023-11-08 |
| 2022-06-30 | $57.34K derived: 10-K 12 month − 10-Q 9 month · filed 2023-08-16 | $114.69K derived: sum of 2 quarters · filed 2023-08-16 | $172.03K derived: sum of 3 quarters · filed 2023-08-16 | $229.38K 10-K · filed 2023-08-16 |
| 2022-03-31 | $57.34K 10-Q · filed 2023-05-12 | $114.69K derived: sum of 2 quarters · filed 2023-05-12 | $172.03K 10-Q · filed 2023-05-12 | $229.38K derived: sum of 4 quarters · filed 2023-05-12 |
| 2021-12-31 | $57.34K 10-Q · filed 2023-02-10 | $114.69K 10-Q · filed 2023-02-10 | $172.03K derived: sum of 3 quarters · filed 2023-02-10 | $229.38K derived: sum of 4 quarters · filed 2023-02-10 |
| 2021-09-30 | $57.34K 10-Q · filed 2022-11-04 | $114.69K derived: sum of 2 quarters · filed 2022-11-04 | $172.03K 10-Q · filed 2022-05-11 | $229.38K derived: sum of 4 quarters · filed 2022-11-04 |
| 2021-06-30 | $57.34K derived: 10-K 12 month − 10-Q 9 month · filed 2022-09-27 | $114.69K derived: sum of 2 quarters · filed 2022-09-27 | $172.03K derived: sum of 3 quarters · filed 2022-09-27 | $229.38K 10-K · filed 2022-09-27 |
| 2021-03-31 | $57.34K 10-Q · filed 2022-05-11 | $114.69K derived: sum of 2 quarters · filed 2022-05-11 | $172.03K 10-Q · filed 2022-05-11 | $229.38K derived: sum of 4 quarters · filed 2022-05-11 |
| 2020-12-31 | $57.34K 10-Q · filed 2022-02-08 | $114.69K 10-Q · filed 2022-02-08 | $172.03K derived: sum of 3 quarters · filed 2022-02-08 | $229.38K derived: sum of 4 quarters · filed 2022-02-08 |
| 2020-09-30 | $57.34K 10-Q · filed 2021-11-10 | $114.69K derived: sum of 2 quarters · filed 2021-11-10 | $172.03K derived: sum of 3 quarters · filed 2021-11-10 | $229.38K derived: sum of 4 quarters · filed 2021-11-10 |
| 2020-06-30 | $57.34K derived: 10-K 12 month − 10-Q 9 month · filed 2021-08-30 | $114.69K derived: sum of 2 quarters · filed 2021-08-30 | $172.03K derived: sum of 3 quarters · filed 2021-08-30 | $229.38K 10-K · filed 2021-08-30 |
| 2020-03-31 | $57.34K 10-Q · filed 2021-05-10 | $114.69K derived: sum of 2 quarters · filed 2021-05-10 | $172.03K 10-Q · filed 2021-05-10 | $229.38K derived: sum of 4 quarters · filed 2021-05-10 |
| 2019-12-31 | $57.34K 10-Q · filed 2021-01-29 | $114.69K 10-Q · filed 2021-01-29 | $172.03K derived: sum of 3 quarters · filed 2021-01-29 | $229.38K derived: sum of 4 quarters · filed 2021-01-29 |
| 2019-09-30 | $57.34K 10-Q · filed 2020-11-05 | $114.69K derived: sum of 2 quarters · filed 2020-11-05 | $172.03K derived: sum of 3 quarters · filed 2020-11-05 | $229.38K derived: sum of 4 quarters · filed 2020-11-05 |
| 2019-06-30 | $57.34K derived: 10-K/A 12 month − 10-Q 9 month · filed 2020-08-07 | $114.69K derived: sum of 2 quarters · filed 2020-08-07 | $172.03K derived: sum of 3 quarters · filed 2020-08-07 | $229.38K 10-K/A · filed 2020-08-07 |
| 2019-03-31 | $57.34K 10-Q · filed 2020-05-13 | $114.69K derived: sum of 2 quarters · filed 2020-05-13 | $172.03K 10-Q · filed 2020-05-13 | $229.38K derived: sum of 4 quarters · filed 2020-05-13 |
| 2018-12-31 | $57.34K 10-Q · filed 2020-02-13 | $114.69K 10-Q · filed 2020-02-13 | $172.03K derived: sum of 3 quarters · filed 2020-02-13 | $229.38K derived: sum of 4 quarters · filed 2020-02-13 |
| 2018-09-30 | $57.34K 10-Q · filed 2019-11-19 | $114.69K derived: sum of 2 quarters · filed 2019-11-19 | $172.03K derived: sum of 3 quarters · filed 2019-11-19 | $229.38K derived: sum of 4 quarters · filed 2019-11-19 |
| 2018-06-30 | $57.34K derived: 10-K 12 month − 10-Q 9 month · filed 2019-09-27 | $114.69K derived: sum of 2 quarters · filed 2019-09-27 | $172.03K derived: sum of 3 quarters · filed 2019-09-27 | $229.38K 10-K · filed 2019-09-27 |
| 2018-03-31 | $57.34K 10-Q · filed 2019-05-10 | $114.69K derived: sum of 2 quarters · filed 2019-05-10 | $172.03K 10-Q · filed 2019-05-10 | $229.38K derived: sum of 4 quarters · filed 2019-05-10 |
| 2017-12-31 | $57.34K 10-Q · filed 2019-02-12 | $114.69K 10-Q · filed 2019-02-12 | $172.03K derived: sum of 3 quarters · filed 2019-02-12 | $229.38K derived: sum of 4 quarters · filed 2019-02-12 |
| 2017-09-30 | $57.34K 10-Q · filed 2018-11-14 | $114.69K derived: sum of 2 quarters · filed 2018-11-14 | $172.03K derived: sum of 3 quarters · filed 2018-11-14 | $229.38K derived: sum of 4 quarters · filed 2018-11-14 |
| 2017-06-30 | $57.34K derived: 10-K 12 month − 10-Q 9 month · filed 2018-10-05 | $114.69K derived: sum of 2 quarters · filed 2018-10-05 | $172.03K derived: sum of 3 quarters · filed 2018-10-05 | $229.38K 10-K · filed 2018-10-05 |
| 2017-03-31 | $57.34K 10-Q · filed 2018-05-14 | $114.69K derived: sum of 2 quarters · filed 2018-05-14 | $172.03K 10-Q · filed 2018-05-14 | |
| 2016-12-31 | $57.34K 10-Q · filed 2018-02-14 | $114.69K 10-Q · filed 2018-02-14 | ||
| 2016-09-30 | $57.34K 10-Q · filed 2017-11-08 | |||
| 2016-06-30 | $51.04K 10-K · filed 2017-08-24 | |||
| 2015-09-30 | $0.00 10-Q/A · filed 2017-01-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |